Peritoneal Recurrence of Gastric Cancer with Mucin Phenotype 12 Years After Curative Resection: Report of a Case

[1]  H. Kuwano,et al.  Clinical significance of mucin phenotype, β‐catenin and matrix metalloproteinase 7 in early undifferentiated gastric carcinoma , 2005, The British journal of surgery.

[2]  H. Kuwano,et al.  Mucin Phenotypic Expression in Early Signet Ring Cell Carcinoma of the Stomach: Its Relationship with the Clinicopathologic Factors , 2004, Digestive Diseases and Sciences.

[3]  H. Katoh,et al.  Evaluation of 18F-2-deoxy-2-fluoro-d-glucose Positron Emission Tomography for Gastric Cancer , 2004, World Journal of Surgery.

[4]  F. Roviello,et al.  Prospective study of peritoneal recurrence after curative surgery for gastric cancer , 2003, The British journal of surgery.

[5]  F. Roviello,et al.  Different Patterns of Recurrence in Gastric Cancer Depending on Lauren’s Histological Type: Longitudinal Study , 2002, World Journal of Surgery.

[6]  A. Teixeira,et al.  Mucins as key molecules for the classification of intestinal metaplasia of the stomach , 2002, Virchows Archiv.

[7]  M. Kusano,et al.  Gastric and Intestinal Phenotypic Marker Expression in Gastric Carcinomas and Its Prognostic Significance: Immunohistochemical Analysis of 136 Lesions , 2001, Oncology.

[8]  K. Karakostas,et al.  Pathological serosa and node-based classification accurately predicts gastric cancer recurrence risk and outcome, and determines potential and limitation of a Japanese-style extensive surgery for Western patients: A prospective with quality control 10-year follow-up study , 2001, British Journal of Cancer.

[9]  A. Ochiai,et al.  Histologic heterogeneity and mucin phenotypic expression in early gastric cancer , 2001, Pathology international.

[10]  E. Tokunaga,et al.  Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer , 2000, The British journal of surgery.

[11]  S. Noh,et al.  Recurrence following curative resection for gastric carcinoma , 2000, The British journal of surgery.

[12]  M. Sobrinho-Simões,et al.  Intestinal metaplasia of human stomach displays distinct patterns of mucin (MUC1, MUC2, MUC5AC, and MUC6) expression. , 1999, Cancer research.

[13]  M. Tatematsu,et al.  Phenotypic shift in human differentiated gastric cancers from gastric to intestinal epithelial cell type during disease progression , 1998, Gastric Cancer.

[14]  J. Jass,et al.  MUC1 and MUC2 mucins in flat and polypoid colorectal adenomas. , 1997, Journal of clinical pathology.

[15]  Y. Kim,et al.  Diversity of mucin genes, structure, function, and expression. , 1995, Gastroenterology.

[16]  J. Dekker,et al.  Biosynthesis of human colonic mucin: Muc2 is the prominent secretory mucin. , 1994, Gastroenterology.

[17]  P. Mouradian,et al.  Oncofetal mucin Ml epitope family: Characterization and expression during colonic carcinogenesis , 1991, International journal of cancer.

[18]  Keiichi Maruyama,et al.  Progress in gastric cancer surgery in Japan and its limits of radicality , 1987, World Journal of Surgery.

[19]  R. Gautier,et al.  Monoclonal antibodies against oncofetal mucin M1 antigens associated with precancerous colonic mucosae. , 1986, Cancer research.

[20]  H. Koyama,et al.  Mechanisms of late recurrence after radical surgery for gastric carcinoma. , 1978, American journal of surgery.

[21]  胃癌研究会.  Japanese classification of gastric carcinoma , 1995 .